The coronavirus vaccine race made 2020-2021 an interesting time to be a biotech investor. Companies announced vaccine programs and saw their shares soar, only to later be crushed by setbacks or ground down by 2022's turbulent bear market.

If you're still hanging onto hope for a few of the vaccine race's laggards, it may be time to wrap it up. And that's particularly true if you're still keeping watch on this pair of stocks.

Image source: Getty Images.

Continue reading

Source Fool.com